Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06297252
Other study ID # RECHMPL23_0189
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 25, 2024
Est. completion date October 24, 2026

Study information

Verified date May 2024
Source University Hospital, Montpellier
Contact Raoul Belzeaux, MD PhD
Phone 04 67 33 79 13
Email raoul.belzeaux@chu-montpellier.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Young women represent a population at risk of psychiatric disorders, the first signs of which often appear between the ages of 15 and 25. Psychiatric disorders are a major source of disability and healthcare costs. The perinatal period is an additional period of psychological vulnerability, during which women are at increased risk of developing or worsening psychiatric disorders. Unfortunately, psychiatric disorders seem to be largely under-diagnosed during this period, and therefore under-treated. The goal of this Prospective multicenter study is to determine the prevalence of the presence of at least one characterized psychiatric disorder, as defined by the use of the Mini International Neuropsychiatric Interview (MINI), in remission or not, during pregnancy, at the time of the second-trimester ultrasound (T2 ultrasound) based on a standardized clinical assessment. Participants will complete self-questionnaires and have a standardized psychiatric evaluation at T2 ultrasound and at 2 months postpartum.


Description:

Young women represent a population at risk of psychiatric disorders, the first signs of which often appear between the ages of 15 and 25. Psychiatric disorders are a major source of disability and healthcare costs. They are often comorbid, and can be complicated by suicidal behaviour. Delays in diagnosis are common, significantly worsening the prognosis and increasing the societal cost of these disorders. The perinatal period is an additional period of psychological vulnerability, during which women are at increased risk of developing or worsening psychiatric disorders. Unfortunately, these disorders seem to be largely under-diagnosed during this period, and therefore under-treated. To date, psychiatric diagnoses are exclusively clinical. They can be facilitated by screening questionnaires, the sensitivity and specificity of which are highly heterogeneous and sometimes poorly understood in the perinatal period and in the general population of pregnant women. What's more, several studies have shown that clinical diagnosis in everyday practice often lacks sensitivity when compared with standardized assessments, i.e. those based on a structured and reproducible diagnostic approach, which is longer and more costly, such as the MINI (Mini International Neuropsychiatric Interview). The state of knowledge on the epidemiology of psychiatric disorders in the perinatal period suffers from many imperfections. The vast majority of studies focus exclusively on postpartum depression. This project, on the other hand, focuses on the diagnosis of any psychiatric disorder characterized by a standardized diagnostic interview (validated and reproducible, like the MINI) carried out by a professional trained in the clinical management of psychiatric disorders. Biomarkers, in particular to aid differential diagnosis, are being developed and are a source of hope for improving the quality of screening; but the results are rarely replicated in independent cohorts or from biological banks associated with quality clinical data. Our hypothesis is that the prevalence of psychiatric disorders (current or in remission), in this population, is at least 20% and that more than half of these disorders are unknown. From a practical point of view, it aims to improve assessments of psychiatric vulnerabilities within the two main public maternity hospitals in the Hérault department in France. From a scientific point of view, it will provide an opportunity to create a highly original bank of biological samples, opening up interesting research prospects in psychiatry, but also well beyond, given the specific nature of the population concerned.


Recruitment information / eligibility

Status Recruiting
Enrollment 140
Est. completion date October 24, 2026
Est. primary completion date April 24, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Women - 18 years and over - Pregnant and consulting for scheduled second trimester ultrasound - Able to read and write with a good knowledge of French Exclusion Criteria: - Unable to understand French - Illiterate - Underage patient at time of second trimester ultrasound - Patient under guardianship or curatorship - Patient deprived of liberty - Patient not affiliated to or not benefiting from a social security scheme - Refusal of consent after information - Participant in another research project with an ongoing exclusion period

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
standardized clinical psychiatric evaluations
The intervention consists of a psychiatric consultation including : assessment of psychiatric disorders using a MINI test information gathering (medical, obstetrical and family history, expected term of pregnancy). assessment of suicidal behaviour using the Columbia-Suicide Severity Rating Scale (CSSR-S) collection of negative life events over the past 12 months, assessed using the Paykel questionnaire
self-administered psychiatric questionnaire assessments
EPICES Score: (Evaluation de la Précarité et des Inégalités de santé dans les Centres d'Examens de Santé): MIBS: (Mother to Infant Bonding Scale) PAI: (Prenatal Attachment Inventory) EDEQ: (Eating Disorder Examination Questionnaire) PCL-5: (Post-traumatic Stress Disorder Checklist for DSM-V) MARS: (Medication Adherence Rating Scale) EPDS: (Edinburgh Postnatal Depression Scale)
Other:
blood sampling
A blood sample is taken to form an optional biological collection, comprising 3 samples: A tube to collect RNA from whole blood. A tube to collect serum A tube to collect native DNA

Locations

Country Name City State
France Centre Hospitalier de Béziers Béziers
France University Hospital of Montpellier Montpellier

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Montpellier Beziers Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary To determine the prevalence of the presence of at least one characterized psychiatric disorder, in remission or not, during pregnancy, at the time of the second-trimester ultrasound (T2 ultrasound) based on a standardized clinical assessment. Presence of at least one psychiatric disorder (evaluated by the MINI), of any kind, in remission or not, during pregnancy, at the time of the T2 ultrasound.
The MINI score verifies the presence or absence of criteria for the most common psychiatric illnesses and assess the 17 most common psychiatric disorders and suicidality in DSM-III-R, DSM-IV and DSM-5 and ICD-10.
Affective Disorders, Psychotic
Agoraphobia
Alcoholism
Anorexia Nervosa
Antisocial Personality Disorder
Anxiety Disorders
Bipolar and Related Disorders
Bipolar Disorder
Bulimia Nervosa
Depressive Disorder, Major
Mania
Obsessive-Compulsive Disorder
Panic Disorder
Phobia, Social
Psychotic Disorders
Self-Injurious Behavior
Stress Disorders, Post-Traumatic
Substance-Related Disorders
Suicidal Ideation
Baseline (T2 ultrasound)
Secondary To determine the prevalence of each psychiatric disorder characterized during pregnancy at the time of the second-trimester ultrasound, based on a standardized clinical assessment. Standardized clinical assessment includes MINI, Columbia-Suicide Severity Rating Scale (CSSR-S) questionnaire used for suicide assessment (scale from 0 to 5 (highest suicidal risk)), Negative life events in the last 12 months will be assessed using the Paykel questionnaire, and a medical examination by a psychiatrist.
All these elements are used together to diagnose psychiatric disorders and determine their individual prevalence.
The MINI score verifies the presence or absence of criteria which assess the 17 most common psychiatric disorders and suicidality : Affective Disorders, Psychotic, Agoraphobia, Alcoholism, Anorexia Nervosa, Antisocial Personality Disorder, Anxiety Disorders, Bipolar and Related Disorders, Bipolar Disorder, Bulimia Nervosa, Depressive Disorder, Major, Mania, Obsessive-Compulsive Disorder, Panic Disorder, Phobia Social, Psychotic Disorders, Self-Injurious Behavior, Stress Disorders, Post-Traumatic, Substance-Related Disorders, Suicidal Ideation
Baseline (T2 ultrasound)
Secondary Determine comorbidity profiles across all pathologies, describing whether there are patient groups based on these profiles. Clustering methods (unsupervised classification) will be used to construct homogeneous subgroups of subjects according to comorbidities. Baseline (T2 ultrasound) and 2 months postpartum
Secondary Compare the prevalence of psychiatric disorders unknown to the obstetrics team with the prevalence of known psychiatric disorders in pregnant patients at the time of T2 ultrasound. Prevalence of diagnoses unknown to the obstetrical team and/or not documented in the obstetrical record. Baseline (T2 ultrasound)
Secondary Compare the prevalence of psychiatric disorders unknown to the patient with the prevalence of known psychiatric disorders in pregnant patients at the time of T2 ultrasound. Prevalence of diagnoses unknown to the patient. Baseline (T2 ultrasound)
Secondary Compare the prevalence of psychiatric disorders unknown to the general practitioner with the prevalence of known psychiatric disorders in pregnant patients at the time of T2 ultrasound. Prevalence of diagnoses unknown to the general practitioner Baseline (T2 ultrasound)
Secondary Assess patients' medication compliance using self-administered questionnaires (MARS). Medication Adherence Report Scale (MARS) 10 items questionnaire with scores ranging from 0 (lowest adhesion) to 10 (highest) Baseline (T2 ultrasound) and 2 months post partum
Secondary Assess patients' treatment beliefs using self-administered questionnaires (BMQ). Belief on Medicine Questionnaire (BMQ) with 18 items, with a scores ranging from 18 (lowest belief) to 90 (highest) Baseline (T2 ultrasound) and 2 months post partum
Secondary Determine the sociodemographic, psychological, psychiatric, medical and obstetric factors, as well as those associated with access to care and the care pathway associated with known or unknown diagnoses during pregnancy. Evaluation of socio-demographic dimension with the French score : Evaluation of precariousness and health inequalities in health examination centers (Evaluation de la Précarité et des Inégalités de santé dans les Centres d'Examens de Santé EPICES). This score assesses the marital status, place of residence, level of education, current employment situation, social security coverage, factors of precariousness. Baseline (T2 ultrasound) and 2 months post partum
Secondary Determine the properties (sensitivity) of screening questionnaires (EPDS) for psychiatric disorders in this population. the results of these tests according to the thresholds already established in the literature will be compared with the results of the corresponding MINI sub-domains, and the sensitivity value will be calculated along with the associated 95% confidence intervals.
- Accuracy of the Edinburgh Postnatal Depression Scale (EPDS) is a 10 items questionnaire with scores ranging from 0 (lowest depression score) to 30 (Highest)
Baseline (T2 ultrasound) and 2 months post partum
Secondary Determine the properties (specificity) of screening questionnaires (EPDS) for psychiatric disorders in this population. the results of these tests according to the thresholds already established in the literature will be compared with the results of the corresponding MINI sub-domains, and the specificity value will be calculated along with their associated 95% confidence intervals.
- Accuracy of the Edinburgh Postnatal Depression Scale (EPDS) is a 10 items questionnaire with scores ranging from 0 (lowest depression score) to 30 (Highest)
Baseline (T2 ultrasound) and 2 months post partum
Secondary Determine the properties (positive predictive value) of screening questionnaires (EPDS) for psychiatric disorders in this population. the results of these tests according to the thresholds already established in the literature will be compared with the results of the corresponding MINI sub-domains, and the positive predictive value will be calculated along with their associated 95% confidence intervals.
- Accuracy of the Edinburgh Postnatal Depression Scale (EPDS) is a 10 items questionnaire with scores ranging from 0 (lowest depression score) to 30 (Highest)
Baseline (T2 ultrasound) and 2 months post partum
Secondary Determine the properties (negative predictive value) of screening questionnaires (EPDS) for psychiatric disorders in this population. the results of these tests according to the thresholds already established in the literature will be compared with the results of the corresponding MINI sub-domains negative predictive value will be calculated along with their associated 95% confidence intervals.
- Accuracy of the Edinburgh Postnatal Depression Scale (EPDS) is a 10 items questionnaire with scores ranging from 0 (lowest depression score) to 30 (Highest)
Baseline (T2 ultrasound) and 2 months post partum
Secondary Determine the properties (sensitivity) of screening questionnaires ( MDQ) for psychiatric disorders in this population. the results of these tests according to the thresholds already established in the literature will be compared with the results of the corresponding MINI sub-domains, and the sensitivity will be calculated along with their associated 95% confidence intervals.
- Mood Disorder Questionnaire (MDQ) composed of 15-items with scores ranging from 0 (lowest risk of mood disorder) to 13 (Highest)
Baseline (T2 ultrasound) and 2 months post partum
Secondary Determine the properties (specificity) of screening questionnaires ( MDQ) for psychiatric disorders in this population. the results of these tests according to the thresholds already established in the literature will be compared with the results of the corresponding MINI sub-domains, and the specificity will be calculated along with their associated 95% confidence intervals.
- Mood Disorder Questionnaire (MDQ) composed of 15-items with scores ranging from 0 (lowest risk of mood disorder) to 13 (Highest)
Baseline (T2 ultrasound) and 2 months post partum
Secondary Determine the properties (positive predictive value) of screening questionnaires ( MDQ) for psychiatric disorders in this population. the results of these tests according to the thresholds already established in the literature will be compared with the results of the corresponding MINI sub-domains, and the positive predictive value will be calculated along with their associated 95% confidence intervals.
- Mood Disorder Questionnaire (MDQ) composed of 15-items with scores ranging from 0 (lowest risk of mood disorder) to 13 (Highest)
Baseline (T2 ultrasound) and 2 months post partum
Secondary Determine the properties (negative predictive value) of screening questionnaires ( MDQ) for psychiatric disorders in this population. the results of these tests according to the thresholds already established in the literature will be compared with the results of the corresponding MINI sub-domains, and the negative predictive value will be calculated along with their associated 95% confidence intervals.
- Mood Disorder Questionnaire (MDQ) composed of 15-items with scores ranging from 0 (lowest risk of mood disorder) to 13 (Highest)
Baseline (T2 ultrasound) and 2 months post partum
Secondary Determine the properties (sensitivity) of screening questionnaires (PCL-5) for psychiatric disorders in this population. the results of these tests according to the thresholds already established in the literature will be compared with the results of the corresponding MINI sub-domains, and the sensitivity will be calculated along with their associated 95% confidence intervals.
- Post-traumatic Stress Disorder Checklist for DSM-V (PCL-5) is a 20 items questionnaires with scores ranging from 0 (lowest risk of PTSD) to 80 (Highest)
Baseline (T2 ultrasound) and 2 months post partum
Secondary Determine the properties (specificity) of screening questionnaires (PCL-5) for psychiatric disorders in this population. the results of these tests according to the thresholds already established in the literature will be compared with the results of the corresponding MINI sub-domains, and the specificity will be calculated along with their associated 95% confidence intervals.
- Post-traumatic Stress Disorder Checklist for DSM-V (PCL-5) is a 20 items questionnaires with scores ranging from 0 (lowest risk of PTSD) to 80 (Highest)
Baseline (T2 ultrasound) and 2 months post partum
Secondary Determine the properties (positive predictive value) of screening questionnaires (PCL-5) for psychiatric disorders in this population. the results of these tests according to the thresholds already established in the literature will be compared with the results of the corresponding MINI sub-domains, and the positive predictive value will be calculated along with their associated 95% confidence intervals.
- Post-traumatic Stress Disorder Checklist for DSM-V (PCL-5) is a 20 items questionnaires with scores ranging from 0 (lowest risk of PTSD) to 80 (Highest)
Baseline (T2 ultrasound) and 2 months post partum
Secondary Determine the properties (negative predictive value) of screening questionnaires (PCL-5) for psychiatric disorders in this population. the results of these tests according to the thresholds already established in the literature will be compared with the results of the corresponding MINI sub-domains, and the negative predictive value will be calculated along with their associated 95% confidence intervals.
- Post-traumatic Stress Disorder Checklist for DSM-V (PCL-5) is a 20 items questionnaires with scores ranging from 0 (lowest risk of PTSD) to 80 (Highest)
Baseline (T2 ultrasound) and 2 months post partum
Secondary Determine the properties (sensitivity) of screening questionnaires (EDEQ) for psychiatric disorders in this population. the results of these tests according to the thresholds already established in the literature will be compared with the results of the corresponding MINI sub-domains, and the sensitivity will be calculated along with their associated 95% confidence intervals.
- Eating Disorder Examination Questionnaire (EDE-Q) is a 28 items questionnaires with a higher score indicating more problematic eating difficulties.
Baseline (T2 ultrasound) and 2 months post partum
Secondary Determine the properties (specificity) of screening questionnaires (EDEQ) for psychiatric disorders in this population. the results of these tests according to the thresholds already established in the literature will be compared with the results of the corresponding MINI sub-domains, specificity will be calculated along with their associated 95% confidence intervals.
- Eating Disorder Examination Questionnaire (EDE-Q) is a 28 items questionnaires with a higher score indicating more problematic eating difficulties.
Baseline (T2 ultrasound) and 2 months post partum
Secondary Determine the properties (positive predictive value) of screening questionnaires (EDEQ) for psychiatric disorders in this population. the results of these tests according to the thresholds already established in the literature will be compared with the results of the corresponding MINI sub-domains, and the positive predictive value will be calculated along with their associated 95% confidence intervals.
- Eating Disorder Examination Questionnaire (EDE-Q) is a 28 items questionnaires with a higher score indicating more problematic eating difficulties.
Baseline (T2 ultrasound) and 2 months post partum
Secondary Determine the properties (negative predictive value) of screening questionnaires (EDEQ) for psychiatric disorders in this population. the results of these tests according to the thresholds already established in the literature will be compared with the results of the corresponding MINI sub-domains, and the negative predictive value will be calculated along with their associated 95% confidence intervals.
- Eating Disorder Examination Questionnaire (EDE-Q) is a 28 items questionnaires with a higher score indicating more problematic eating difficulties.
Baseline (T2 ultrasound) and 2 months post partum
Secondary Compare mother-child bonding difficulties between patients with and without a psychiatric diagnosis at the time of the study, using scales (PAI). - Personality Assessment Inventory (PAI) 21 items questionnaire with scores ranging from 21 (the least feeling for their baby) to 84 (Highest) 2 months post partum
Secondary Compare mother-child bonding difficulties between patients with and without a psychiatric diagnosis at the time of the study, using scales (MIBS). - Mother-to-Infant Bonding Scale (MIBS) 8 items questionnaire with scores ranging from 0 (highest Bonding) to 24 (Lowest) 2 months post partum
Secondary Describe how the study will be carried out, either in person or by teleconsultation, and the reasons for this choice. Percentage of face-to-face and teleconsultation consultations and the reasons for this choice Baseline (T2 ultrasound) and 2 months post partum
Secondary Determine the prevalence of each psychiatric disorder at two months post-inclusion based on a standardized clinical assessment. Standardized clinical assessment includes MINI, Columbia-Suicide Severity Rating Scale (CSSR-S) questionnaire used for suicide assessment (scale from 0 to 5 (highest suicidal risk)), Negative life events in the last 12 months will be assessed using the Paykel questionnaire, and a medical examination by a psychiatrist.
All these elements are used together to diagnose psychiatric disorders and determine their individual prevalence.
The MINI score verifies the presence or absence of criteria which assess the 17 most common psychiatric disorders and suicidality : Affective Disorders, Psychotic, Agoraphobia, Alcoholism, Anorexia Nervosa, Antisocial Personality Disorder, Anxiety Disorders, Bipolar and Related Disorders, Bipolar Disorder, Bulimia Nervosa, Depressive Disorder, Major, Mania, Obsessive-Compulsive Disorder, Panic Disorder, Phobia Social, Psychotic Disorders, Self-Injurious Behavior, Stress Disorders, Post-Traumatic, Substance-Related Disorders, Suicidal Ideation
2 months post partum
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Completed NCT02566005 - A Randomized Comparison of Transcervical Foley Bulb With Vaginal Misoprostol to Vaginal Misoprostol Alone for Induction of Labor N/A